Literature DB >> 6490653

Detergent solubilization and affinity purification of a local anesthetic binding protein from mammalian axonal membranes.

M Greenberg, T Y Tsong.   

Abstract

Previously, we identified a local anesthetic receptor in the membranes of nerve cells, especially enriched in axonal membranes, by the binding assay of a fluorescence local anesthetic probe, quinacrine (Greenberg, M., and Tsong, T.Y. (1982) J. Biol. Chem. 257, 8964-8971). We report here affinity chromatography purification of the quinacrine binding protein from axonal membranes of bovine brain. One per cent sodium cholate solubilized more than 90% of the membrane proteins, and the quinacrine binding activity was preserved in the extract; KD remained at 1.0 microM. An affinity column of quinacrine mustard covalently linked to Affi-Gel 10 (Bio-Rad) retained about 5% of the total solubilized proteins, and the subsequent elution with 1.0 M lidocaine revealed a protein peak which coeluted with the lidocaine peak. After removal of lidocaine, the protein peak retained the high affinity to quinacrine (KD = 1.5 microM). Furthermore, bound quinacrine could be displaced with dibucaine in the range of its nerve-blocking concentration, around 10 microM. Sodium dodecyl sulfate-gel electrophoresis of the peak protein fractions gave a predominant band of approximately 16 kDa. A major protein band with the same molecular weight was also seen in the sodium dodecyl sulfate gel of the total axonal membrane proteins. The receptor concentration in the axonal membranes was estimated to be 2-5 nmol/mg protein. With a molecular weight of 16 kDa, the receptor should constitute 3-8% of total proteins, consistent with the finding that it is a major protein constituent of the axonal membranes. The purity of the binding protein after the affinity chromatography step was about 90%. The purified protein contained roughly 60 nmol of quinacrine binding sites/mg.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490653

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Phorbol dibutyrate enhances local anaesthetic action.

Authors:  S Austin; J McGivern; C N Scholfield
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

2.  Procaine isothiocyanate: an irreversible inhibitor of the specific binding of [3H]batrachotoxinin-A benzoate to sodium channels.

Authors:  C R Creveling; M E Bell; T R Burke; E Chang; G A Lewandowski-Lovenberg; C H Kim; K C Rice; J W Daly
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

3.  The effect of bupivacaine.HCl on the physical properties of neuronal membranes.

Authors:  K I Koo; J H Bae; C H Lee; C D Yoon; J H Pyun; S H Shin; Y C Jeon; M K Bae; H O Jang; W G Wood; I Yun
Journal:  Protoplasma       Date:  2008-09-17       Impact factor: 3.356

Review 4.  Whole blood pathogen reduction technology and blood safety in sub-Saharan Africa: A systematic review with regional discussion.

Authors:  Asa'ah Nkohkwo; Gabriel Agbor; Emmanuel Asongalem; Claude Tagny; Tazoacha Asonganyi
Journal:  Afr J Lab Med       Date:  2016-06-09

5.  Method for recovery and immunoaffinity enrichment of membrane proteins illustrated with metastatic ovarian cancer tissues.

Authors:  Luke V Schneider; Varsha Likhte; William H Wright; Frances Chu; Emma Cambron; Anne Baldwin-Burnett; Jessica Krakow; Gary B Smejkal
Journal:  Int J Proteomics       Date:  2012-07-12

6.  Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens.

Authors:  Leticia H Higa; Laura Arnal; Mónica Vermeulen; Ana Paula Perez; Priscila Schilrreff; Cecilia Mundiña-Weilenmann; Osvaldo Yantorno; María Elena Vela; María José Morilla; Eder Lilia Romero
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.